Nephrogenic systemic fibrosis and gadolinium exposure: Association and lessons for idiopathic fibrosing disorders
Open Access
- 28 September 2007
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 56 (10), 3173-3175
- https://doi.org/10.1002/art.22926
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Cutaneous changes of nephrogenic systemic fibrosis: Predictor of early mortality and association with gadolinium exposureArthritis & Rheumatism, 2007
- Nephrogenic Systemic FibrosisClinical Journal of the American Society of Nephrology, 2007
- Nephrogenic Systemic FibrosisInvestigative Radiology, 2007
- Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy)Current Opinion in Rheumatology, 2006
- Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosisProceedings of the National Academy of Sciences, 2006
- Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosisJournal of Hepatology, 2006
- Nephrogenic Systemic Fibrosis: The Nosological and Conceptual Evolution of Nephrogenic Fibrosing DermopathyAmerican Journal of Kidney Diseases, 2005
- Presence of CD45RO+ CD34+ cells with collagen synthesis activity in nephrogenic fibrosing dermopathy: a new pathogenic hypothesisBritish Journal of Dermatology, 2004
- Scleromyxoedema-like cutaneous diseases in renal-dialysis patientsThe Lancet, 2000
- Association of the Eosinophilia–Myalgia Syndrome with the Ingestion of TryptophanNew England Journal of Medicine, 1990